Delayed rod‐mediated dark adaption, the first functional biomarker for early AMD, is observed for both the age‐related maculopathy susceptibility 2 (ARMS2) A69S variant and the CFH Y402H variant in AMD patients. This evidence concerns the gene CFH and age-related macular degeneration.